🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/04/2007 54,60 55,20 52,00 52,70 -3,30% 5,86% 18.540
16/04/2007 54,70 57,10 53,50 54,50 +2,66% 6,58% 25.580
13/04/2007 52,90 53,50 52,30 53,09 +1,12% 2,27% 10.820
12/04/2007 50,00 55,00 49,90 52,50 +6,06% 10,20% 28.740
11/04/2007 48,80 50,01 48,30 49,50 +1,02% 3,50% 15.680
10/04/2007 48,30 49,70 47,60 49,00 +2,08% 4,35% 14.410
09/04/2007 46,50 48,10 45,40 48,00 +4,48% 5,81% 7.330
05/04/2007 45,70 46,70 45,30 45,94 -0,13% 3,06% 9.860
04/04/2007 47,90 47,90 45,50 46,00 -2,13% 5,01% 9.250
03/04/2007 47,80 48,20 45,60 47,00 +4,91% 5,44% 13.020
02/04/2007 45,60 46,70 44,70 44,80 +0,20% 4,39% 10.390
30/03/2007 43,80 45,50 43,70 44,71 +3,02% 4,11% 8.890
29/03/2007 43,00 45,00 40,50 43,40 +0,93% 10,47% 32.110
28/03/2007 45,40 46,30 41,80 43,00 -5,08% 9,91% 18.920
27/03/2007 47,40 47,40 45,20 45,30 -2,16% 4,64% 10.470
26/03/2007 46,50 48,20 45,58 46,30 +0,65% 5,63% 26.480
23/03/2007 44,30 46,20 44,26 46,00 +4,55% 4,38% 22.790
22/03/2007 41,00 44,81 39,50 44,00 +15,18% 12,95% 41.890
21/03/2007 40,50 42,10 37,50 38,20 -5,21% 11,36% 179.210
20/03/2007 37,60 41,10 37,60 40,30 +5,25% 9,31% 26.130
19/03/2007 38,80 40,20 38,00 38,29 -1,06% 5,67% 12.380
16/03/2007 36,50 41,60 36,50 38,70 +4,88% 13,97% 30.230
15/03/2007 36,80 38,90 35,60 36,90 -0,81% 8,97% 5.680
14/03/2007 36,30 37,20 35,50 37,20 +2,48% 4,68% 2.930
13/03/2007 36,70 37,50 36,00 36,30 -1,09% 4,09% 3.200
12/03/2007 37,50 38,00 36,70 36,70 -2,91% 3,47% 3.550
09/03/2007 37,40 38,40 37,40 37,80 +2,44% 2,67% 1.980
08/03/2007 38,40 38,40 36,90 36,90 -0,27% 3,91% 3.610
07/03/2007 37,20 37,50 36,80 37,00 +0,00% 1,88% 2.660
06/03/2007 36,60 37,79 36,20 37,00 +2,78% 4,34% 3.860